Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107 Claritas Pharmaceuticals, Inc.April 21, 2021 GMT SAN FRANCISCO and TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CM...
South Australia United States South Korea Robert Farrell Funding For The Company Phase Company Or Claritas
Source: apnews.com